Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. REDX.L Share Price
  4. REDX.L Share Regulatory News
  5. Redx Pharma

Pin to quick picksREDX.L Regulatory News (REDX)

REDX.L Information
  • There is currently no data for REDX

Redx Pharma

9 Apr 2020 18:10

RNS Number : 4476J
FTSE Russell
09 April 2020
 

 

 

 

 

Redx Pharma (UK): Constituent DeletionChanges in FTSE UK Index Series

09 April 2020

Following the cash offer for Redx Pharma (UK, constituent) by RM Special Holdings LLC (non constituent) being declared unconditional in all respects, please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

16 April 2020

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSSSFWUESSESL
12345678910
Date   Source Headline
20th Mar 202310:38 amRNSForm 8.5 (EPT/RI)
16th Mar 20239:48 amRNSForm 8.5 (EPT/RI)
15th Mar 20234:40 pmRNSSecond Price Monitoring Extn
15th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20232:05 pmRNSSecond Price Monitoring Extn
15th Mar 20232:00 pmRNSPrice Monitoring Extension
15th Mar 202310:50 amRNSStatement re: Jounce Therapeutics Press Release
14th Mar 202311:45 amRNSResult of Annual General Meeting
10th Mar 20237:00 amRNSForm 8.3 - Redx Pharma Plc
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20232:00 pmBUSForm 8.3 - REDX PHARMA PLC
9th Mar 202311:22 amRNSForm 8 (OPD) - Jounce Therapeutics, Inc
9th Mar 202311:15 amRNSForm 8 (OPD) - Redx Pharma Plc
9th Mar 20238:34 amRNSForm 8.5 (EPT/RI)
9th Mar 20237:00 amRNSForm 8.3 - Redx Pharma plc
8th Mar 20239:05 amRNSSecond Price Monitoring Extn
8th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20238:38 amRNSForm 8.5 (EPT/RI)
8th Mar 20238:16 amRNSForm 8 (OPD) Jounce Therapeutics, Inc.
8th Mar 20237:00 amRNSRXC004 Topline Data From a Phase 2 Module
7th Mar 20238:30 amRNSForm 8.5 (EPT/RI)
3rd Mar 20233:08 pmRNSForm 8.3 - Jounce Therapeutics, Inc.
2nd Mar 20238:09 amRNSForm 8.5 (EPT/RI)
1st Mar 20238:48 amRNSForm 8.5 (EPT/RI)
1st Mar 20237:00 amRNSRedx to Present at Cowen Health Care Conference
28th Feb 20236:03 pmRNSForm 8.3 - Jounce Therapeutics, Inc.
27th Feb 20234:58 pmRNSForm 8.3 - Jounce Therapeutics, Inc
27th Feb 20234:47 pmRNSForm 8.3 - Redx Pharma plc
27th Feb 20234:36 pmRNSForm 8.3 - Jounce Therapeutics, Inc
27th Feb 20232:40 pmRNSForm 8.3 - Jounce Therapeutics, Inc.
27th Feb 20238:48 amRNSForm 8.5 (EPT/RI)
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
24th Feb 20233:13 pmRNSReplacement Form 8.3 - Jounce Therapeutics, Inc.
24th Feb 20232:02 pmRNSForm 8.3 - Jounce Therapeutics, Inc.
24th Feb 202310:18 amRNSForm 8.5 (EPT/RI)
24th Feb 20237:00 amRNSForm 8.3 - Redx Pharma plc
23rd Feb 20237:15 amRNSRecommended Business Combination
23rd Feb 20237:01 amRNSRecommended Business Combination
15th Feb 20234:38 pmRNSNotice of AGM
9th Feb 20237:00 amRNSProgress Update on RXC007 Clinical Programme
23rd Jan 20237:00 amRNSRedx to Present at Wnt & ß-Catenin Pathway Summit
21st Dec 20227:00 amRNSNew Grant of Options
20th Dec 20227:00 amRNSFinal Results for the Year Ended 30 September 2022
16th Dec 20227:00 amRNSClinical Trial Agreement with MSD
13th Dec 20227:00 amRNSNotice of Preliminary Results
17th Nov 20227:00 amRNSRedx to Present Poster at IBD Nordic Conference
10th Nov 20222:00 pmRNSRXC004 Phase 2 Combination Arms to Open Enrolment
10th Nov 20227:00 amRNSRedx to Present at Jefferies London
7th Nov 20227:00 amRNSRedx Presenting at AFDD meeting
3rd Nov 20227:00 amRNSRedx to Present RXC004 Phase 1 Combination Data
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
0A40
0A40.L
LSE
0.00%
NWT
Newmark Security
LSE
0.00%
BOS
Bos Glb Hldgs
LSE
0.00%
VNET
Vianet Grp
LSE
0.72%
PAM
Pottermoore
LSE
0.00%
Trending
MPL
Mercantile Ports & Logistics
LSE
26.92%
PREM
Premier African Minerals
LSE
-7.61%
FORG
Forgent
LSE
-5.26%
HEX
Helix Exploration
LSE
-0.67%
AVCT
Avacta Group
LSE
-1.40%